Insights

Immunotherapy Pioneers3T Biosciences is a pioneering immunotherapy company focused on developing transformative therapies for solid tumors and immune-mediated diseases. This emphasis on innovation and cutting-edge technology presents sales opportunities to partner with healthcare providers seeking novel treatment solutions.

Strategic PartnershipsThe strategic partnerships with industry leaders like Boehringer Ingelheim highlight 3T Biosciences' collaborative approach to advancing cancer immunotherapies. Leveraging these partnerships can open doors for sales representatives to explore joint ventures and expand market reach.

Expansion and Growth3T Biosciences' recent expansions in leadership team appointments signify the company's growth trajectory. Sales development representatives can capitalize on this growth by offering specialized products or services that cater to the evolving needs of a rapidly expanding biotechnology research company.

Technological AdvancementsWith a tech stack featuring Cloudflare CDN, Microsoft Azure, and Amazon Web Services, 3T Biosciences demonstrates a commitment to cutting-edge technology. Sales professionals can leverage this technological prowess to offer complementary services or products that enhance the company's digital infrastructure and operational efficiency.

Market Positioning and FundingDespite strong market positioning indicated by partnerships and revenue growth, 3T Biosciences' funding of $40M suggests room for investment in new solutions. Sales development teams can seize this opportunity by pitching cost-effective sales solutions that align with the company's financial objectives and growth strategies.

Similar companies to 3T Biosciences

3T Biosciences Tech Stack

3T Biosciences uses 8 technology products and services including Cloudflare CDN, Webpack, Modernizr, and more. Explore 3T Biosciences's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Webpack
    Development
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Scala
    Programming Languages
  • C++
    Programming Languages
  • Slider Revolution
    Widgets

Media & News

3T Biosciences's Email Address Formats

3T Biosciences uses at least 1 format(s):
3T Biosciences Email FormatsExamplePercentage
First.Last@3tbiosciences.comJohn.Doe@3tbiosciences.com
46%
Last@3tbiosciences.comDoe@3tbiosciences.com
6%
First@3tbiosciences.comJohn@3tbiosciences.com
2%
First.Last@3tbiosciences.comJohn.Doe@3tbiosciences.com
46%

Frequently Asked Questions

Where is 3T Biosciences's headquarters located?

Minus sign iconPlus sign icon
3T Biosciences's main headquarters is located at 681 Gateway Blvd South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is 3T Biosciences's official website and social media links?

Minus sign iconPlus sign icon
3T Biosciences's official website is 3tbiosciences.com and has social profiles on LinkedIn.

How much revenue does 3T Biosciences generate?

Minus sign iconPlus sign icon
As of January 2025, 3T Biosciences's annual revenue reached $3.8M.

What is 3T Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
3T Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 3T Biosciences have currently?

Minus sign iconPlus sign icon
As of January 2025, 3T Biosciences has approximately 30 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: S. J. S.Chief Business Officer: C. D.Chief Research Officer, Co-Founder: M. G.. Explore 3T Biosciences's employee directory with LeadIQ.

What industry does 3T Biosciences belong to?

Minus sign iconPlus sign icon
3T Biosciences operates in the Biotechnology Research industry.

What technology does 3T Biosciences use?

Minus sign iconPlus sign icon
3T Biosciences's tech stack includes Cloudflare CDNWebpackModernizrjQueryPHPScalaC++Slider Revolution.

What is 3T Biosciences's email format?

Minus sign iconPlus sign icon
3T Biosciences's email format typically follows the pattern of . Find more 3T Biosciences email formats with LeadIQ.

How much funding has 3T Biosciences raised to date?

Minus sign iconPlus sign icon
As of January 2025, 3T Biosciences has raised $40M in funding. The last funding round occurred on Aug 25, 2022 for $40M.

When was 3T Biosciences founded?

Minus sign iconPlus sign icon
3T Biosciences was founded in 2017.
3T Biosciences

3T Biosciences

Biotechnology ResearchCalifornia, United States11-50 Employees

3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.

By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is advancing the development of next-generation therapies that have the potential to be safer, more effective, and even curative for difficult-to-treat cancers.

Section iconCompany Overview

Headquarters
681 Gateway Blvd South San Francisco, California 94080 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $40M

    3T Biosciences has raised a total of $40M of funding over 3 rounds. Their latest funding round was raised on Aug 25, 2022 in the amount of $40M.

  • $10M

    3T Biosciences's revenue is in the range of $10M

Section iconFunding & Financials

  • $40M

    3T Biosciences has raised a total of $40M of funding over 3 rounds. Their latest funding round was raised on Aug 25, 2022 in the amount of $40M.

  • $10M

    3T Biosciences's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.